ACE and COVID-19: A population-based case-control study in the UK showed that antihypertensive therapy including angiotensin-converting enzyme inhibitors, angiotensin receptor blockers, beta-blockers, calcium-channel blockers, thiazide diuretics, and other antihypertensive drugs is not associated with an increased risk of COVID-19 diagnosis or mortality, as most antihypertensive classes showed negative associations with COVID-19 diagnosis [34].